About the Journal

Instructions to Authors

Available in the Author's Guideline document at:

https://s3-us-west-2.amazonaws.com/clarivate-scholarone-prod-us-west-2-s1m-public/wwwRoot/prod4/societyimages/bjps-scielo/Guidelines.pdf

Journal History

The Brazilian Journal of Pharmaceutical Sciences has its origin in 1939 with the publication of the "Anais de Farmácia e Odontologia da USP". In 1963, the Journal name changed to "Revista da Faculdade de Farmácia e Bioquímica da Universidade de São Paulo" and in 1970 the Journal was renamed again as "Revista de Farmácia e Bioquímica da Universidade de São Paulo".

In 1999, the Journal was totally remodeled and renamed Revista Brasileira de Ciências Farmacêuticas/Brazilian Journal of Pharmaceutical Sciences. From 2009 on, celebrating 70 years of publishing, a new era started. The Journal adopted exclusively the English denomination and at present accepts only papers in English. In addition, in 2019 it moved to a continuous publishing model.

All these changes aimed at increasing the national and international visibility of the Brazilian Journal of Pharmaceutical Sciences and speeding the process of publication towards consolidating it as one of the main journals in Pharmaceutical Sciences.

The abbreviation is Braz. J. Pharm. Sci., which should be used in bibliographies, footnotes and bibliographical references and strips.

SCOPE AND POLICY

The purpose of the Brazilian Journal of Pharmaceutical Sciences is to publish manuscripts that significantly contribute to knowledge in all areas of Pharmaceutical Sciences. The area of focus shall be concepts in basic and applied pharmaceutical sciences including:

  •  Medicinal Chemistry, Drug Discovery and Development, Pharmacognosy;
  •  Pharmaceutical Technology, Drug Delivery;
  •  Clinical Pharmacy and Pharmacokinetics, Pharmaceutical Care, Pharmaceutical Services;
  •  Clinical-Bioanalytical Chemistry and Pharmaceutical Analysis;
  •  Food Science and Nutrition, focusing on Nutrigenomics, Immunonutrition, Functional foods and supplements, Food bioactive compounds, and Food and drug interactions;
  •  Vaccines and Biologicals;
  •  Cosmetology;
  •  Toxicology

Editorial Process

All manuscripts undergo an initial evaluation to check for the presence of all required attachments (such as figures and a signed copyright form) as well as the correct text format. If the manuscript meets these initial criteria, it is then reviewed by the Editor-in-Chief to assess the quality of the content and its alignment with the Journal’s scope and basic policies. Following this, the manuscript is subjected to a single-blind peer review process. Based on the feedback from this review, the Editor-in-Chief makes a decision regarding the need for a second review, and determines whether the manuscript should be accepted, revised (requiring major or minor revisions), or rejected.

Peer Review Process

Manuscripts submitted to the Brazilian Journal of Pharmaceutical Sciences must conform to the journal's scope, undergo an initial plagiarism check by the author, and be accompanied by a plagiarism report certificate. Submissions are evaluated and, if compliant, reviewed by at least two anonymous reviewers that will evaluate the manuscript regarding novelty, scientific importance, organization, clarity, conciseness, analytical and critical skills, and adequate references. Based on these opinions, the Associate Editor makes a preliminary recommendation, which is forwarded to the Editor-in-Chief. The Editor-in-Chief makes the final decision on the manuscript, which can be accepted, rejected, or returned for revisions. This decision is communicated to the authors.

Authors receive feedback within approximately 60 days and, if revisions are needed, must submit a revised manuscript within 30 days. The authors must justify to the Editor in case additional time is needed to prepare the revised version. The revised text must be typed in black and highlighted in yellow and accompanied by a rebuttal letter discussing each point raised by the reviewers in a point-by-point manner. The rebuttal letter should also indicate the page and line number where each revision has been made. If the revised manuscript and rebuttal letter are not submitted within this timeframe, the manuscript will be withdrawn from the system. Revised manuscripts are reassessed, and the final decision on acceptance, rejection, or further revisions is based on this review and the editors' assessment.

In line with open science principles, starting in 2024, accepted articles will be published along with the name of the editor responsible for handling and accepting the study.

Open Data

In line with the principles of Open Science to enhance transparency and verifiability, the Brazilian Journal of Pharmaceutical Sciences encourages the sharing of data, codes, methods, and other materials that are used in and result from the research published in the Journal. Starting in 2024, research data from manuscripts accepted for publication should be deposited in the SciELO Data repository, which is currently being developed. This includes all forms of data that support the research findings, such as raw and processed data, audio and video files, code, software, algorithms, protocols, and methods. This practice is encouraged to facilitate data verification and reuse, thereby increasing the credibility and impact of the research published.

Preprints

The Brazilian Journal of Pharmaceutical Sciences recognizes the importance of new scientific mediums and enables readers and researchers to have faster access to recent research findings prior to its publication. Therefore, the journal welcomes manuscripts that have been deposited on non-commercial preprint servers.

A preprint is a preliminary version of a scientific work that is publicly shared in online repositories before undergoing peer review and eventual publication in a scientific journal. It is a way to accelerate the process of scientific communication, enabling researchers to promptly share their findings with the academic community.

Preprints can be found in public repositories such as bioRxiv and medRxiv, dedicated to biology and medicine publications, respectively. These repositories, maintained by non-profit organizations, provide free access to the public for reading and downloading purposes.

To ensure transparency and integrity in handling preprints submitted to the Brazilian Journal of Pharmaceutica Sciences, authors are encouraged to provide the following information:

  1. Preprint Identification: Authors must provide information about the preprint, including its title, authors, repository name where it was published, publication date and DOI.
  2. Relationship with the Submitted Work: Authors should clarify the connection between the preprint and the work submitted to the journal, for example, if the preprint is an earlier version or if it contains complementary information.
  3. Conflicts of Interest: Authors should disclose any conflicts of interest related to the preprint, such as funding from a company or institution with an interest in the work.

Article Processing Charge (APC)

There are no charges for articles submission, evaluation, and publication.

Sponsors

The Journal receives financial support from: Programa de Apoio às Publicações Científicas Periódicas da USP.

Indexing sources

The Journal is indexed and recognized by several prestigious databases and systems, which underscores its credibility and reach within the scientific community. Here is a summary of the indexing and classification details:

Sources of Support